...cell and gene therapy business well and will be long-term partners with us,” he said. Jeff Cranmer Gracell Biotechnologies Co. Ltd. bee2021 CAR...

...innovating around next-generation antibodies. A notable example is Gracell Biotechnologies Co. Ltd....

...CFO to fill in for Michael McDonnell, who is joining Biogen Inc. (NASDAQ:BIIB) as CFO. Gracell Biotechnologies Co. Ltd....
...Holdings Inc. Replimune Group Inc. Cellectis S.A. Gamida Cell Ltd. Lakewood-Amedex Inc. Windtree Therapeutics Inc. Triplet Therapeutics Inc. Twist Bioscience Corp. Verrica Pharmaceuticals Inc. Gracell Biotechnologies Co. Ltd. Asklepios...

...No. 3014 ), a CD7-targeting CAR T cell for T cell acute lymphoblastic leukemia from Gracell Biotechnologies Co. Ltd....

...first look at Phase I data from allogeneic CAR T therapy GC027 from Chinese biotech Gracell Biotechnologies Co. Ltd....

...No. DDT-02-04 and No. DDT-0301 ), along with an allogeneic CAR T cell therapy from Gracell Biotechnologies Co. Ltd....

...for FasT CAR-19 in B cell ALL Preliminary data showed that FasT CAR-19 (GC007F) from Gracell Biotechnologies Co. Ltd....
...RG7446 (Compound #), MPDL3280A (Compound #), atezolizumab (Generic), Tecentriq (Other), Anti-PDL1 (Other) Cancer Prevention Pharmaceuticals Inc. Exelixis Inc. Genentech Gracell Biotechnologies Co. Ltd. Progenics...

...day, Gracell is lining up a set of therapies it could produce with the method. Gracell Biotechnologies Co. Ltd....
...years of runway and the company plans another round of financing next year. COMPANY PROFILE Gracell Biotechnologies Co. Ltd....
...William) Cao Patents: NA Companies and Institutions Mentioned Gilead Sciences Inc. (NASDAQ:GILD), Foster City, Calif. Gracell Biotechnologies Co. Ltd....

...leukemia (ALL). The data reported Tuesday also showed that the therapy, dubbed CD19-F-CAR-T, was safe. Gracell Biotechnologies Co. Ltd....
...by Temasek (see "Gracell Raises $85M Series B to Advance Cell Therapies" ). Hongjiang Li, Staff Writer Gracell Biotechnologies Co. Ltd. CD19 CD19-F-CAR-T FasT...

...Point Raises $93M series B” ). Meanwhile, Temasek led an $85 million B round for Gracell Biotechnologies Co. Ltd....